MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
Cellectar Biosciences, Inc. (CLRB)
Cellectar Biosciences, Inc. (CLRB)
source: myfinsight.com
Download
Download image
Net (decrease)
increase in cash and cash...
-$4,848,943
Stock-based compensation
expense
$451,869
Accounts payable and
accrued liabilities
$301,278
Prepaid expenses and
other current assets
-$245,498
Cash used in
operating activities
-$4,845,565
Cash used in
investing activities
-$3,378
Canceled cashflow
$998,645
Net loss
-$5,653,946
Purchases of property,
plant & equipment
$3,378
Depreciation and
amortization
-$110,018
Change in fair value of
warrants
-$77,000
Change in operating
lease right-of-use...
-$3,246
Back